Fig. 1.
Fig. 1. Platelet aggregation using chemokine agonists. / (A) Platelet aggregation data using human washed platelets. Platelets were stimulated with 100 nmol/L chemokine (as shown) or 10 μmol/L ADP in the presence of 1 mmol/L CaCl2 and 200 μg/mL fibrinogen. (B) Ca++–flux data using Fura-2–loaded washed platelets involving 30 nmol/L MDC activation. This activation was inhibited by prior incubation of the platelets with 20 U/mL apyrase, as shown in the middle of the figure. The activation specificity is shown by the ability of 20 μg/mL anti-MDC antibody to block MDC-induced platelet activation, as shown on the right side of the figure.

Platelet aggregation using chemokine agonists.

(A) Platelet aggregation data using human washed platelets. Platelets were stimulated with 100 nmol/L chemokine (as shown) or 10 μmol/L ADP in the presence of 1 mmol/L CaCl2 and 200 μg/mL fibrinogen. (B) Ca++–flux data using Fura-2–loaded washed platelets involving 30 nmol/L MDC activation. This activation was inhibited by prior incubation of the platelets with 20 U/mL apyrase, as shown in the middle of the figure. The activation specificity is shown by the ability of 20 μg/mL anti-MDC antibody to block MDC-induced platelet activation, as shown on the right side of the figure.

Close Modal

or Create an Account

Close Modal
Close Modal